Radioconjugate Scientist - IHC
AstraZeneca · Hamilton, Ontario, Canada · Global
Clinical Research
–
Not yet analysed
Demand70
Career growth65
Healthcare fit45
Remote potential–
5-year outlook
Competitive for a senior lab scientist in pharma, likely in the six-figure range with experience, but exact figures depend on location and company.
Clinical license
Not required
Applicant reach
narrow
Seniority
mid
Employment type
full-time
Date found
2026-09-17
Intelligence details
Why this is worth applying to
Clinicians with strong laboratory and histology backgrounds may find this a compelling pivot into pharma R&D, but it requires specialized technical skills not typical of clinical practice. Only consider if you have direct experience with tissue processing and imaging.
Who should apply
Allied health professionals (e.g., medical laboratory scientists, pathologists' assistants) with histology and IHC experience, or healthcare graduates with advanced lab training in oncology research.
CV angle
Emphasize hands-on histology, IHC/IF, tissue imaging, and quantitative analysis skills. Highlight any experience with radiolabeled materials, oncology research, or GLP compliance. Frame clinical experience as evidence of attention to detail, scientific rigor, and ability to work in regulated environments.
Skills to highlight
- Histology
- Immunohistochemistry (IHC)
- Immunofluorescence (IF)
- Tissue imaging
- Quantitative image analysis (HALO)
- Assay development
- Radiation safety
- Oncology research
Role summary
A scientist role at AstraZeneca's radiopharmaceutical division, developing and running histology and tissue-based assays to support early-stage drug discovery for radioconjugates.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.